Novo Nordisk A/S ADR (NVO) Stock Price, Quote & News

Company Profile

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products i...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 45 44 44 88 88

Website: www.novonordisk.com

Address:

Novo Alle 1, Bagsvaerd, Denmark

MartinAT Jan. 3 at 12:41 PM

$NVO overweight people will all want the pill, easy reliable as effective way cheaper better flexibility no cold storage etc. 97% of the market is untapped in the US, worldwide even less. Extrapolate the numbers. Compounding will be severely restricted and ineffective

0 · Reply

MartinAT Jan. 3 at 12:35 PM

$NVO company insiders and rumours of Market participants, healthcare etc very optimistic re Novo Pill! Demand huge

0 · Reply

MartinAT Jan. 3 at 12:33 PM

$NVO https://finance.yahoo.com/news/fda-approves-novo-nordisks-wegovy-220500876.html

0 · Reply

icervantes Jan. 3 at 9:37 AM

$NVO 🐂🐂🐂🐂🐂🐂🐂

0 · Reply

catchnthevibe Jan. 3 at 3:36 AM

$NVO Sure seemed like a little rotation into value today. Here's to a great year for NOVO. Cheers!

1 · Reply

SaneProton Jan. 3 at 2:21 AM

$NVO Enjoy your weekend bulls. It begins on Monday.

1 · Reply

ZTRADEZ_LLC Jan. 3 at 1:02 AM

$NVO | Those $60's don't look bad, TA is lining up well.

0 · Reply

PaulBurke55 Jan. 3 at 12:03 AM

$IBBQ $PRFZ $NVO $ONDS $USAR Spurred by positive news, the market is climbing rapidly.

0 · Reply

tylero2 Jan. 2 at 11:22 PM

$NVO another big after hours transaction. Since this is a continuation of the last 3 or 4 trading days of huge after hours transactions I am a bit more confident they are not tax loss harvesting.

2 · Reply

PaulBurke55 Jan. 2 at 11:10 PM

$OSCR $NVO $MSTR $IWM $GHRS Highly unified bullish expectations are driving prices upward.

0 · Reply

Novo Nordisk enters 2026 on the defense as it faces a ‘must-win' battle in the U.S. market

Dec 31, 2025, 8:24 AM EST - 2 days ago

Novo Nordisk A/S: China's Supreme People's Court delivers a positive ruling on the semaglutide compound patent

Dec 30, 2025, 1:12 AM EST - 4 days ago

Novo Nordisk's 'long game' on weight loss drugs sparks hope in science, but the Street is impatient

Dec 29, 2025, 7:51 AM EST - 5 days ago

Novo cuts Wegovy prices in some Chinese provinces, local media reports

Dec 28, 2025, 10:00 AM EST - 5 days ago

Novo Nordisk: Oral Weight-Loss To The Rescue

Dec 28, 2025, 8:00 AM EST - 6 days ago

Potentially 12%-15% Consistent Income: Monthly Options Series (January 2026)

ALB AMAT APH AU CIB GLW GM

Dec 26, 2025, 2:18 PM EST - 7 days ago

Oral Wegovy Approval Is The Critical 2026 Lifeline Novo Nordisk Needs

Dec 24, 2025, 11:45 AM EST - 9 days ago

Novo Nordisk: The Real Comeback Starts Now With The Wegovy Pill

Dec 24, 2025, 10:00 AM EST - 9 days ago

NVO Weight-Loss Pill Approved

Dec 24, 2025, 9:21 AM EST - 9 days ago

GLP-1 weight-loss pills set to reshape US food demand in 2026

LLY

Dec 23, 2025, 8:06 PM EST - 10 days ago

Focus: Lilly, Novo lock horns in India's obesity drug race

LLY

Dec 23, 2025, 6:25 PM EST - 10 days ago

Final Trade: NVO, FCX, BA, CLF

FCX BA CLF

Dec 23, 2025, 6:06 PM EST - 10 days ago

Launch of Wegovy pill is core to Novo Nordisk's growth, says Guggenheim's Seamus Fernandez

Dec 23, 2025, 4:56 PM EST - 10 days ago

US health agency to expand access to GLP-1 weight-loss drugs

LLY

Dec 23, 2025, 4:52 PM EST - 10 days ago

Dr. Ashish Jha talks Novo Nordisk getting approval for Wegovy pill

Dec 23, 2025, 3:04 PM EST - 10 days ago

Novo Nordisk is still worried about revenue growth next year despite obesity pill: BMO's Seigerman

Dec 23, 2025, 2:51 PM EST - 10 days ago

FDA approves Novo Nordisk weight-loss pill. Here's what to know

Dec 23, 2025, 2:04 PM EST - 10 days ago

Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus

IBB PPH VHT XBI

Dec 23, 2025, 1:42 PM EST - 10 days ago

Novo Nordisk stock: does oral Wegovy approval make it better pick than Eli Lilly?

Dec 23, 2025, 12:06 PM EST - 10 days ago

Lexaria Says Oral GLP-1 Cuts Side Effects Nearly 50% Versus Novo Nordisk's Rybelsus

LEXX

Dec 23, 2025, 11:58 AM EST - 10 days ago

Novo Nordisk gets US approval for Wegovy obesity pill

Dec 23, 2025, 11:45 AM EST - 10 days ago

Could Novo Nordisk's New Weight-Loss Pill Be Just What Its Stock Needs?

Dec 23, 2025, 11:16 AM EST - 10 days ago

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

Dec 23, 2025, 10:30 AM EST - 10 days ago

Novo Nordisk's Christmas Gift To Shareholders: The Wegovy Pill Has Been Approved

Dec 23, 2025, 9:42 AM EST - 10 days ago

Novo Going 'All-In' With Wegovy Weight Loss Pill

Dec 23, 2025, 9:06 AM EST - 10 days ago

Novo CEO Says Wegovy Pill Is Safe and Will Be Widely Available

Dec 23, 2025, 8:54 AM EST - 10 days ago

Eli Lilly Vs. Novo Nordisk: Which Stock Could Lead Pharma's 2026 Comeback

LLY

Dec 23, 2025, 7:46 AM EST - 11 days ago

Novo Nordisk's new obesity pill, Alphabet's data center deal, the end of EV euphoria and more in Morning Squawk

GOOG GOOGL

Dec 23, 2025, 7:08 AM EST - 11 days ago

Explainer: What Novo Nordisk's weight-loss pill approval means for company, patients

Dec 23, 2025, 6:30 AM EST - 11 days ago

Eli Lilly Stock Falls. Novo Nordisk Got a Wegovy Weight-Loss Pill Approved in U.S.

LLY

Dec 23, 2025, 6:29 AM EST - 11 days ago

Wall Street Breakfast Podcast: Wegovy Without The Needle Sparks Novo Surge

NVDA

Dec 23, 2025, 5:18 AM EST - 11 days ago

Novo Nordisk first out of the gate with oral weight-loss drug, and its stock jumps

Dec 23, 2025, 5:05 AM EST - 11 days ago

Novo Nordisk Shares Jump After FDA Approves Pill Version of Wegovy

Dec 23, 2025, 3:02 AM EST - 11 days ago

Shares in Wegovy-maker Novo Nordisk pop 6% after GLP-1 pill approval

Dec 23, 2025, 2:18 AM EST - 11 days ago

Novo Nordisk up nearly 10% in Frankfurt after US approves weight loss pill

Dec 23, 2025, 1:57 AM EST - 11 days ago

Novo Gets Approval to Sell Wegovy Obesity Pill in the US

Dec 23, 2025, 1:06 AM EST - 11 days ago

Novo's Wegovy pill to test demand from consumers with cash

Dec 22, 2025, 6:09 PM EST - 11 days ago

FDA approves first GLP-1 pill for obesity from Novo Nordisk

Dec 22, 2025, 6:05 PM EST - 11 days ago

The FDA has approved the first GLP-1 pill for weight loss, clearing a tablet from Novo Nordisk

Dec 22, 2025, 5:59 PM EST - 11 days ago

Novo Nordisk wins US approval for weight-loss pill

Dec 19, 2025, 12:49 PM EST - 14 days ago

These 5 Stocks Are Set To Dominate 2026

AMZN ASML CRM GOOG GOOGL HIMS NBIS

Dec 19, 2025, 10:45 AM EST - 14 days ago

Trump to announce new drug-pricing deals later today

ABBV AMGN AZN BMY GILD LLY MRK

Dec 19, 2025, 8:00 AM EST - 15 days ago

Novo Nordisk: Oral Wegovy, Supply Chain, And Restructuring = Big Upside Ahead

Dec 18, 2025, 9:09 AM EST - 15 days ago

Wegovy Maker Novo Nordisk Files For FDA Approval of Obesity Drug CagriSema

Dec 16, 2025, 2:29 PM EST - 17 days ago

Healthy Returns: 2026 will be the year of obesity pills from Novo Nordisk, Eli Lilly

LLY

Dec 16, 2025, 6:48 AM EST - 18 days ago

Novo Nordisk Loses Momentum As Eli Lilly Pulls Ahead In Weight-Loss Wars

LLY

Dec 15, 2025, 6:22 PM EST - 18 days ago

Final Trade: JNJ, NVO, UBER, BMY

BMY JNJ UBER

Dec 12, 2025, 9:30 AM EST - 21 days ago

EU drugs regulator backs higher dose of Novo's Wegovy

Dec 12, 2025, 8:57 AM EST - 21 days ago

Novo Nordisk A/S: More efficacious dose of Wegovy® recommended by the European Medicines Agency can help people with obesity achieve an average of 20.7% weight loss

Dec 12, 2025, 7:41 AM EST - 22 days ago

Novo Nordisk Launches $24 a Week Ozempic in This Country. Why the Big Price Cut.

MartinAT Jan. 3 at 12:41 PM

0 · Reply

MartinAT Jan. 3 at 12:35 PM

$NVO company insiders and rumours of Market participants, healthcare etc very optimistic re Novo Pill! Demand huge

0 · Reply

MartinAT Jan. 3 at 12:33 PM

$NVO https://finance.yahoo.com/news/fda-approves-novo-nordisks-wegovy-220500876.html

0 · Reply

icervantes Jan. 3 at 9:37 AM

$NVO 🐂🐂🐂🐂🐂🐂🐂

0 · Reply

catchnthevibe Jan. 3 at 3:36 AM

$NVO Sure seemed like a little rotation into value today. Here's to a great year for NOVO. Cheers!

1 · Reply

SaneProton Jan. 3 at 2:21 AM

$NVO Enjoy your weekend bulls. It begins on Monday.

1 · Reply

ZTRADEZ_LLC Jan. 3 at 1:02 AM

$NVO | Those $60's don't look bad, TA is lining up well.

0 · Reply

PaulBurke55 Jan. 3 at 12:03 AM

$IBBQ $PRFZ $NVO $ONDS $USAR Spurred by positive news, the market is climbing rapidly.

0 · Reply

tylero2 Jan. 2 at 11:22 PM

$NVO another big after hours transaction. Since this is a continuation of the last 3 or 4 trading days of huge after hours transactions I am a bit more confident they are not tax loss harvesting.

2 · Reply

PaulBurke55 Jan. 2 at 11:10 PM

$OSCR $NVO $MSTR $IWM $GHRS Highly unified bullish expectations are driving prices upward.

0 · Reply

Th3339 Jan. 2 at 10:59 PM

$NVO i have jan 27 60 call leap. anyones thoughts. sell or hold for months or a specific reasonable price target

1 · Reply

Turk41 Jan. 2 at 10:44 PM

$NVO let’s see

0 · Reply

SaneProton Jan. 2 at 10:29 PM

$NVO I give him credit for being a good b!+ch because he listened to me telling him to post again. He does as he’s told like he should. Good boy 🐶

1 · Reply

sister Jan. 2 at 10:19 PM

$MRNA $PFE of one thing you can be sure regardless of Calendar Flip . . . Can always get these cheaper. $NVO too

0 · Reply

PaulBurke55 Jan. 2 at 10:05 PM

$OSRH $GOOG $BINI $CETY $NVO Buying pressure is overwhelmingly dominant.

0 · Reply

TopWaterSniper Jan. 2 at 10:03 PM

$NVO Serious question. Semaglutide patents have expired so it is now generic. Obviously Lilly is going to have a pill soon but does the pill create a new patent on this delivery format which won’t cut out Lilly, Pfizer, and others but does it stop the fuckery with the compounded semaglutide the price undercutters are using like Ro and Hims?

1 · Reply

tylero2 Jan. 2 at 10:01 PM

$NVO

0 · Reply

YoloAlfred Jan. 2 at 9:56 PM

$AMTM $S $NVO Dan I'm rolling with GOODRX I feel it's bottom and undervalued

0 · Reply

EmbraceVolatility Jan. 2 at 9:53 PM

$NVO Looking good. Hopefully $50.50 is new support. Anyone having avg under $45 is lucky af.

1 · Reply

MartinAT Jan. 2 at 9:47 PM

$NVO 150 actually conservative. Look at the numbers, do the math and extrapolate! Go!

0 · Reply

FujiLeBandido Jan. 2 at 9:46 PM

$NVO the highest point of the day is the close.... bullish af!

0 · Reply

The_Wealth_Maker Jan. 2 at 9:37 PM

$LEXX $NVO $PFE

0 · Reply

Market Cap	227.18B
Revenue (ttm)	42.11B
Net Income (ttm)	14.64B
EPS (ttm)	N/A
PE Ratio	13.41
Forward PE	14.34
Profit Margin	34.78%
Debt to Equity Ratio	0.60

Volume	12,134,100
Avg Vol	18,473,154
Day's Range	N/A - N/A
Shares Out	4.47B
Stochastic %K	79%
Beta	0.67
Analysts	Sell
Price Target	$52.21